If you are considering investing in the stock market, you should know about OCGN Stock. This article gives you a detailed overview of ONGC’s Stock price forecast, stock market sentiments, future conditions, and much more.
Ocugen Inc. (NASDAQ: OCGN)
Ocugen Inc. is a biotechnology US-based company. It is focused on developing innovative treatments & cell therapy development.
This company’s founder’s name is Shankar Musunuri and the company was founded in 2013. and its headquarters in Malvern, Pennsylvania United States.
| Ocugen Inc. Overview | |
| Details | Information |
| Stock Name | Ocugen Inc |
| Stock Symbol | OCGN |
| Stock Exchange | NASDAQ |
| Market Cap | 216.93M USD |
| Founder | Shankar Musunuri |
| Founded Year | 2013 |
| Headquarter | Malvern, Pennsylvania United States |
Fundamentals Of the OCGN Stock
If we talk about the fundamentals of OCGN Stock its stock average trading volume is 5.56M, the total equity is 40.56M, and its Dividend yield is 0 other stock details are given in the table below.
| Company | Data |
| AVG Volume | 5.56M |
| Revenue Growth % (Yearly) | 142.60% |
| Net Income | -63.08M |
| ROE | -154.75% |
| EPS | -0.26 |
| P/B Ratio | 5.44 |
| P/E Ratio | – |
| Dividend Yield | – |
| Total Equity | 40.56M |
| Net profit margin | -1.05K |
| EBITDA Margin | -0.26 |
| Effective tax rate | – |
OCGN Stock Price History Chart
Now in this paragraph, we know the OCGN Stock Price History this stock’s primary exchange is NASDAQ.
This stock was listed on a stock exchange on November 6, 2014. Its lowest price in this stock history is $0.30 and its highest price in this stock is $663.00 and the starting price of this stock was $7.50 per share.
| Time | Per Share Value (USD) |
| Previous close | $0.72 |
| Day Range | $0.70 – $0.72 |
| Before 5D | $0.75 |
| Before 1M | $0.75 |
| Before 6M | $1.64 |
| Before 1Y | $0.52 |
| 52 Week Range | $0.49 – $2.11 |
| Before 5Y | $0.73 |
| All time Max | $663.00 |
| All time lowest | $0.30 |
| Starting | $7.50 |
Major Shareholders of OCGN Stock
The major shareholders of OCGN stock are BlackRock Advisors LLC which holds 6.16 % shares of this stock and the second largest shareholder is Vanguard Fiduciary Trust Co. which has 5.82 % shares.
| Shareholder | Shares % |
| BlackRock Advisors LLC | 6.16 % |
| Vanguard Fiduciary Trust Co. | 5.82 % |
| State Street Corporation | 5.44 % |
| Geode Capital Management LLC | 2.16 % |
| GMT Capital Corp | 0.85 % |
Upcoming 1 to 10-Year OCGN Stock Forecast
Now we will provide you the upcoming 1 to 10-year OCGN Stock Forecast price which is based on past performance & the current trend.
| Year | Minimum Per Stock Value | Maximum Per Stock Value |
| 1 Year | $ 0.879 | $ 1.067 |
| 2 Year | $0.796 | $1.479 |
| 3 Year | $1.485 | $1.998 |
| 4 Year | $1.513 | $2.489 |
| 5 Year | $1.784 | $2.037 |
| 6 Year | $1.850 | $2.095 |
| 7 Year | $2.548 | $2.876 |
| 8 Year | $3.223 | $3.890 |
| 9 Year | $4.105 | $4.819 |
| 10 Year | $10.070 | $10.309 |
OCGN Stock Forecast 2025
OCGN’s stock price forecast for 2025 is expected to be $ 0.879 per share which is the minimum stock price of OCGN. The maximum stock price of OCGN is expected to be $ 1.067.
| Year | 2025 |
| Minimum Per Stock Price | $ 0.879 |
| Maximum Per Stock Price | $ 1.067 |
| Average Per Stock Price | $0.973 |
OCGN Stock Forecast 2026
OCGN Stock Forecast Price for 2026 minimum & maximum per stock value is $0.796 and $1.479 based on the current trend.
| Year | 2026 |
| Minimum Per Stock Price | $0.796 |
| Maximum Per Stock Price | $1.479 |
| Average Per Stock Price | $1.052 |
OCGN Stock Forecast 2027
The average estimated stock price forecast for 2027 will be $1.750 with the lower estimation of $1.485 and the maximum estimation of $1.998 per share.
| Year | 2027 |
| Minimum Per Stock Price | $1.485 |
| Maximum Per Stock Price | $1.998 |
| Average Per Stock Price | $1.750 |
OCGN Stock Forecast 2030
OCGN stock forecast for 2030 is expected to be $2.095 to $1.850 per share and the average stock price will be $1.970.
| Year | 2030 |
| Minimum Per Stock Price | $1.850 |
| Maximum Per Stock Price | $2.095 |
| Average Per Stock Price | $1.970 |
Ocugen Stock Forecast 2035
Ocugen’s stock forecast for 2035 is expected to be $11.235 per share which is the average price prediction of this stock. The maximum stock price will be $11.880 with the lower estimation of $10.751.
| Year | 2035 |
| Minimum Per Stock Price | $10.751 |
| Maximum Per Stock Price | $11.880 |
| Average Per Stock Price | $11.235 |
OCGN Stock Price Prediction 2025 to 2040 Chart
OCGN stock price prediction from 2025 to the upcoming years is presented in the table below. You can get an idea before investing in this stock.
| Year | Minimum Per Stock Value | Maximum Per Stock Value |
| 2025 | $ 0.879 | $ 1.067 |
| 2026 | $0.796 | $1.479 |
| 2027 | $1.485 | $1.998 |
| 2028 | $1.513 | $2.489 |
| 2029 | $1.784 | $2.037 |
| 2030 | $1.850 | $2.095 |
| 2031 | $2.548 | $2.876 |
| 2032 | $3.223 | $3.890 |
| 2033 | $4.105 | $4.819 |
| 2034 | $10.070 | $10.309 |
| 2035 | $10751 | $11.880 |
| 2040 | $15.840 | $16.789 |
Influencing Key Factors of the OCGN Stock
Biotech Industry Growth: If the biotech industry grows in the future then it allow the growth of biotech companies and the result is market share of OCGN will go high.
R&D Outcomes: If the research on medicines or every kind of product is successful then the market share goes high.
Last 5-Year Financial Data Chart of the OCGN Stock
The financial condition of this stock is very bad. You can see the company has been in heavy loss for the last few years and also generates revenue like nothing.
Ocugen Inc. generated $6.04M in revenue in 2023 but if we see the profit of this year then the company was in loss of -$63.08M which is more than 10 times from the revenue.
| Year | Revenue Of OCGN Stock | Net income of OCGN Stock | Total Assets of OCGN Stock |
| 2019 | – | -$20.24M | $16.81M |
| 2020 | $43.00K | -$21.82M | $27.38M |
| 2021 | – | -$58.37M | $105.76M |
| 2022 | $2.49M | -$86.80M | $108.63M |
| 2023 | $6.04M | -$63.08M | $64.55M |
Also Read – SYM Stock Forecast (Symbotic): 2025 To 2035
Challenges & Risks of OCGN Stock
Clinical Trial Outcomes: The major risk for the Ocugen is the failure of clinical trials. If the prosecution fails then the market share goes down.
Regulatory Delays: Fast approval can increase revenue and the company’s entire growth, and delays in approval can badly affect this growth.
Market Volatility: Market volatility is also a major risk in this sector because the biotech sector is volatile.
Final Thought
The market share of Ocugen Inc. has been in very bad condition for the last few years. The company also is at a huge loss and never recover its principles.
So, if you are thinking of investing in this stock then you should wait for changing the financial condition of this company.
Frequently Ask Questions (FAQs)
Is OCGN stock a good investment?
No, if you have sufficient risk tolerance power then you can go with this stock for the long-term investment.
What is the price target of OCGN stock in 2025?
The price target of OCGN stock for the year 2025 is estimated to be $ 1.067.
What is the price target of OCGN stock in 2030?
The price target of OCGN stock for the year 2030 is estimated to be $2.095.
What is the price target of OCGN stock in 2035?
The stock price target of OCGN for 2035 is estimated to $11.880.